Business Description
Emmessar Biotech And Nutrition Ltd
ISIN : INE634B01016
Total Employee Number:
16Compare
Compare
Traded in other countries / regions
524768.India IPO Date
1995-02-28Description
Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.85 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 6.35 | |||||
Beneish M-Score | -3.3 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -28.6 | |||||
3-Year EPS without NRI Growth Rate | -3.7 | |||||
3-Year FCF Growth Rate | -9.8 | |||||
3-Year Book Growth Rate | 6.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.59 | |||||
9-Day RSI | 54.95 | |||||
14-Day RSI | 52.63 | |||||
3-1 Month Momentum % | -6.69 | |||||
6-1 Month Momentum % | -2.76 | |||||
12-1 Month Momentum % | -16.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 20.27 | |||||
Quick Ratio | 20.02 | |||||
Cash Ratio | 19.68 | |||||
Days Inventory | 329.13 | |||||
Days Sales Outstanding | 17.26 | |||||
Days Payable | 11.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.87 | |||||
Operating Margin % | -392.31 | |||||
Net Margin % | 117.56 | |||||
EBITDA Margin % | 184.03 | |||||
FCF Margin % | 69.22 | |||||
OCF Margin % | 71.51 | |||||
ROE % | 5.49 | |||||
ROA % | 4.63 | |||||
ROIC % | -49.84 | |||||
3-Year ROIIC % | 112.86 | |||||
ROC (Joel Greenblatt) % | 49.28 | |||||
ROCE % | 6.48 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.68 | |||||
PE Ratio without NRI | 29.68 | |||||
Shiller PE Ratio | 12.94 | |||||
Price-to-Owner-Earnings | 39.06 | |||||
PS Ratio | 34.82 | |||||
PB Ratio | 1.59 | |||||
Price-to-Tangible-Book | 1.56 | |||||
Price-to-Free-Cash-Flow | 50.13 | |||||
Price-to-Operating-Cash-Flow | 48.53 | |||||
EV-to-EBIT | 8.73 | |||||
EV-to-EBITDA | 7.45 | |||||
EV-to-Revenue | 13.7 | |||||
EV-to-FCF | 18.07 | |||||
Price-to-GF-Value | 1.36 | |||||
Price-to-Projected-FCF | 0.96 | |||||
Price-to-Median-PS-Value | 3.07 | |||||
Price-to-Graham-Number | 1.42 | |||||
| Price-to-Net-Current-Asset-Value | 1.98 | |||||
| Price-to-Net-Cash | 2.05 | |||||
Earnings Yield (Greenblatt) % | 11.45 | |||||
FCF Yield % | 2.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Emmessar Biotech And Nutrition Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3.707 | ||
| EPS (TTM) (₹) | 0.868 | ||
| Beta | 1.1436 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.05 | ||
| Volatility % | 35.81 | ||
| 14-Day RSI | 52.63 | ||
| 14-Day ATR (₹) | 1.365989 | ||
| 20-Day SMA (₹) | 24.9 | ||
| 12-1 Month Momentum % | -16.64 | ||
| 52-Week Range (₹) | 18.42 - 42.75 | ||
| Shares Outstanding (Mil) | 5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Emmessar Biotech And Nutrition Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Emmessar Biotech And Nutrition Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Emmessar Biotech And Nutrition Ltd Frequently Asked Questions
What is Emmessar Biotech And Nutrition Ltd(BOM:524768)'s stock price today?
The current price of BOM:524768 is ₹25.34. The 52 week high of BOM:524768 is ₹42.75 and 52 week low is ₹18.42.
When is next earnings date of Emmessar Biotech And Nutrition Ltd(BOM:524768)?
The next earnings date of Emmessar Biotech And Nutrition Ltd(BOM:524768) is .
Does Emmessar Biotech And Nutrition Ltd(BOM:524768) pay dividends? If so, how much?
Emmessar Biotech And Nutrition Ltd(BOM:524768) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Emmessar Biotech And Nutrition Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers